홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
MIRM
#1168
Mirum Pharmaceuticals, Inc. Common Stock
92.290
0
+0.51%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.51%
월간 변동
-8.40%
6달 변화
+31.60%
년간 변동율
+31.60%
이전 종가
91.820
0
Open
92.110
0
Bid
Ask
Low
92.110
0
High
92.290
0
양
133
마켓
주식
헬스케어
MIRM
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
30.42 M
31.73 M
37.95 M
47 M
49.01 M
60.34 M
—
Valuation ratios
Enterprise value
389.04 M
474.76 M
703.69 M
1.12 B
1.8 B
4.47 B
12.3 B
Price to earnings ratio
—
—
-4.8
-7.5
-22.35
-168.06
-325.38
Price to sales ratio
—
—
8.5
6.59
5.83
7.61
26.96
Price to cash flow ratio
—
—
5.45
17.3
190.32
71.03
-261.54
Price to book ratio
—
—
4.61
4.94
8.71
12.6
21.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.43
-0.29
-0.38
-0.25
-0.13
-0.03
-0.03
Return on equity %
-0.6
-0.7
-0.96
-0.66
-0.39
-0.07
-0.09
Return on invested capital %
-2 442.39
-1 010.86
-339.27
-197.68
-125.01
-28.12
-34.74
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-906.12
-170.28
-58.57
-26
-4.25
-22.53
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
-438.85
-176.05
-87.68
-26.1
-4.48
-19.4
Liquidity ratios
Quick ratio
—
3.88
2.85
4.19
2.93
2.55
11.73
Current ratio
12.8
3.91
2.94
4.45
3.1
2.67
12.33
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.24
0.37
0.51
0.69
0.7
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.47
0.46
0.37
1.63
Long term debt to total equity ratio
—
—
—
1.23
1.37
0.98
4.58
Per share metrics
Operating cash flow per share
—
—
-3.54
-1.74
0.22
1.11
1.02
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.46
7
5.9
7.64
26.03
Net current asset value per share
—
—
5.6
9.48
8.27
10.95
37.78
Tangible book value per share
—
—
2.44
-0.1
-0.51
1.07
2.26
Working capital per share
—
—
3.69
7.35
5.6
6.85
25.35
Book value per share
—
—
4.18
6.08
4.75
6.27
21.3
뉴스
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Leerink, Mirum Pharmaceuticals 목표 주가 $118로 하향
에버코어 ISI, 미룸 파마슈티컬스 ’아웃퍼폼’ 투자의견 재확인
Leerink cuts Mirum Pharmaceuticals stock price target to $118
Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform
미룸 파마슈티컬 주가, R&D 지출 전망에 하락… RBC ’시장수익률 상회’ 유지
Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)
미럼 제약 목표 주가 하향, Citizens
Citizens cuts Mirum Pharmaceuticals stock price target on valuation
Mirum Pharmaceuticals Q4 실적 에상치보다 저조, 수익 예상치를 넘어